Jane A. Gross

CIK: 0001684258

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ATYR

aTYR PHARMA INC

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ATYR
aTYR PHARMA INC
May 11, 2026
Award(A)
Stock Option (right to buy)
Direct
50K shares-
ATYR
aTYR PHARMA INC
May 1, 2025
Award(A)
Stock Option (right to buy)
Direct
50K shares-
ATYR
aTYR PHARMA INC
Mar 17, 2025
Purchase(P)
Direct
3.8K shares at avg. $4.00$15K

		Type	Shares	Price		Ownership
May 11, 2026	ATYR aTYR PHARMA INC	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
May 1, 2025	ATYR aTYR PHARMA INC	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Mar 17, 2025	ATYR aTYR PHARMA INC	Purchase(P)	3,750	$4.00	$15,000	Direct

1-3 of 3 transactions

About Gross Jane A

Gross Jane A (SEC CIK 0001684258) files insider reports with the SEC as Director of aTYR PHARMA INC (ATYR).

Signal8 holds 3 ownership filings by Gross Jane A, all Form 4s, filed between Mar 17, 2025 and May 13, 2026. Those filings report 3 transactions, from Mar 17, 2025 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gross Jane A's filings is in SAN DIEGO, CA.

Recent filings by Gross Jane A

May 11, 2026: Grant or award of ATYR derivative securities (Form 4, code A).
May 1, 2025: Grant or award of ATYR derivative securities (Form 4, code A).
Mar 17, 2025: Open-market purchase of ATYR shares (Form 4, code P).

Other insiders filing for aTYR PHARMA INC (ATYR)

Yaras Brandon, Chief Financial Officer
SCHIMMEL PAUL, Director
Coughlin Timothy, Director
BENEVICH ERIC, Director
Lucas Svetlana, Director
Zaknoen Sara, Director

How to read Form 4 transaction codes